Wolverine Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Wolverine Trading’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-39,400	Closed	-$62K	–	5413
2022 Q3	$62K	Buy	+39,400	New	+$89.4K	﹤0.01%	4084
2022 Q2	–	Sell	-33,500	Closed	-$79K	–	6121
2022 Q1	$79K	Buy	+33,500	New	+$104K	﹤0.01%	4919
2021 Q4	–	Sell	-157,500	Closed	-$1.17M	–	7219
2021 Q3	$1.17M	Buy	157,500 +9,600	+6%	+$81.4K	﹤0.01%	2796
2021 Q2	$1.44M	Sell	147,900 -8,000	-5%	-$63.7K	﹤0.01%	2359
2021 Q1	$1.25M	Sell	155,900 -19,800	-11%	-$209K	﹤0.01%	2473
2020 Q4	$1.27M	Buy	175,700 +71,200	+68%	+$572K	﹤0.01%	2130
2020 Q3	$1.21M	Buy	+104,500	New	+$956K	﹤0.01%	1894

Other funds holding SRNE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wolverine Trading's SRNE Position: Q2 2021 in Review

Wolverine Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2021, closing a stake of 13,452 shares — an estimated $107K sold.

Wolverine Trading first reported a position in SRNE in Q4 2020 and held it in 2 quarters. The position peaked at $441K in Q4 2020. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

Wolverine Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Wolverine Trading sold 13,452 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $107K.
Wolverine Trading first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
Wolverine Trading's Sorrento Therapeutics, Inc. position peaked at $441K in Q4 2020.
212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.